期刊文献+

胺碘酮对急诊老年快速心房颤动患者的疗效观察 被引量:7

The Effects of Amiodarone on Emergency Elderly Patients with Atrial Fibrillation
原文传递
导出
摘要 目的:通过与传统控制心室率的药物去乙酰毛花苷注射液进行对比,探讨胺碘酮注射液对老年快速型心房颤动患者的临床疗效。方法:选择2010年5月~2012年6月我院急诊科收治的老年快速房颤患者60例,按就诊先后顺序随机分为对照组与胺碘酮治疗组,每组30例。胺碘酮治疗组患者先给予胺碘酮注射液150 mg以生理盐水稀释后缓慢静脉注射,继以0.5 mg/min静滴;对照组患者先予去乙酰毛花苷注射液0.2 mg稀释后缓慢静脉推注,若20 min无效则再次给药,两组患者的院内观察周期均为24h,患者在观察过程中行全程心电监护,观察不同时间段(用药后0、0.5、2、12、24 h)患者的心室率,血压的变化;比较两种治疗方法的临床疗效及对患者复律情况的影响。结果:治疗前,两组患者的心室率比较无显著性差异(P〉0.05);第一次用药后0.5 h,两组患者的心室率都较治疗前显著下降(P〈0.01),且用乙酰毛花苷注射液治疗的对照组显著低于胺碘酮治疗组(P〈0.05);用药后2和12h,两组患者的心室率比较均无显著性差异(P〉0.05);用药后24h,胺碘酮治疗组患者的心室率较对照组显著降低(P〈0.01)。对照组的临床有效率为40.0%,复律率为16.7%;而胺碘酮治疗组的临床有效率为73.3%,复律率为43.3%,分别显著高于对照组(P〈0.01)。与用药前比较,用药后0.5、2、12和24h患者的收缩压略有下降,但差异均无统计学意义(P〉0.05)。结论:与去乙酰毛花苷注射液比较,胺碘酮注射液可更有效地降低老年患者24 h心室率,复律率和有效率更高,但在应用过程中需注意其不良反应。 Objective: To investigate the effect of Amiodarone on elderly patients with atrial fibrillation through comparing with the effect of Lanatoside C.Methods: Sixty elderly patients with atrial fibrillation admitted in the emergency ward of our hospital(from 2010.5 to 2012.6) were randomly divided into two groups according to the visiting sequence,the control group and the Amiodarone group,thirty patients in each group.The patients in Amiodarone group were first given 150 mg amiodarone injection slowly via intravenous injection,the Amiodarone injection was diluted with saline followed by 0.5 mg/min infusion.The patients in control group were first given 0.2 mg Lanatoside C injection,if ineffective after 20min,the given 0.2 mg Lanatoside C injection once again via intravenous.The observing time of all the patients was 24 h.During the observing time,the patients were processed line full ECG,blood pressure monitoring.The ventricular rate and the systolic blood pressure were recorded at 0,0.5,2,12,24 h after the drugs were given;the clinical effects and the auricular fibrillation situation were also observed.Results: There was no significant difference of the ventricular rate between two groups before therapy(P0.05).0.5 h after the drugs injection for the first time,the ventricular rate both decreased significantly in the two groups(P0.01),which was lower in the control group than in the Amiodarone group(P0.05).2 h and 12 h after the drugs injection,there was no significant difference of ventricular rate between two groups(P0.05).but at the end of 24 h after therapy for the first time,the ventricular rate of Amiodarone group was lower than that of the Lanatoside C group(P0.01).There were significant differences in both clinical efficiency(40.0% vs 73.3%) and cardioversion rate(16.7% vs 43.3) between the two therapy methods(P0.01).Compared with before therapy,the systolic blood pressure decreased slightly 0.5 h,2 h,12 h and 24 h after the drugs injection(P0.05).Conclusion: Compared with the Lanatoside C injection,Amiodarone injection may be more effective in reducing the 24 h ventricular rate of the elderly patients with atrial fibrillation,and had higher clinical effect rate and auricular fibrillation,but adverse reactions should be paid attention to during the treatment.
出处 《现代生物医学进展》 CAS 2013年第13期2557-2561,共5页 Progress in Modern Biomedicine
关键词 快速房颤 胺碘酮 乙酰毛花苷 老年患者 Rapid atrial fibrillation Amiodarone Lanatoside C Elderly patients
  • 相关文献

参考文献16

  • 1Skanes AC, Healey JS, Cairns JA, et al. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control [J]. Can J Cardiol,2012,28:125-136.
  • 2Lopes RD, Al-Khatib SM, Wallentin L, et al. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial[J]. Lancet,2012,380:1749-1758.
  • 3Carom AJ, Lip GY, De Caterina R, et al. Focued update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation- developed with the special contribution of the European Heart Rhythm Association[J]. Eurooace.2012,14:1385-1413.
  • 4施仲伟.2010年欧洲新指南带来心房颤动防治新概念[J].中国处方药,2010,9(11):66-68. 被引量:1
  • 5杨延宗,刘莹.老年房颤发生机制的研究进展[J].中国处方药,2007,6(2):49-51. 被引量:6
  • 6Reznik EV, Gendlin GE, Storozhakov GL. Relation of Renal Function, Microalbuminuria and Renal Blood Flow with Atrial Fibrillation in Chronic Heart Failure (Chf) [J]. Hypertension,2010,56:1179-1180.
  • 7Konishi M, Haraguchi G, Kimura S, et al. Comparative Effects of Carvedilol vs Bisoprolol for Severe Congestive Heart Failure-Special Reference to Atrial Fibrillation[J]. Circulation Journal,2010,74:1127- 1134.
  • 8蒋文平.胺碘酮抗心律失常治疗应用指南(2008)[J].中国心脏起搏与心电生理杂志,2008,22(5):377-385. 被引量:144
  • 9Sinner M, Greiner MA, Mi X J, et al. Guideline Recommended Evaluation in Patients with a First Episode of Atrial Fibrillation [J]. Circulation,2011:124.
  • 10Warm LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. Circulation,2011,123:104-123.

二级参考文献23

共引文献170

同被引文献45

  • 1Okechukwu S Ogah,Ikechi Okpechi,Innocent I Chukwuonye,Joshua O Akinyemi,Basden JC Onwubere,Ayodele O Falase,Simon Stewart,Karen Sliwa.Blood pressure,prevalence of hypertension and hypertension related complications in Nigerian Africans:A review[J].World Journal of Cardiology,2012,4(12):327-340. 被引量:13
  • 2蒋文平,杨向军.胺碘酮应用指南解读[J].中国心脏起搏与心电生理杂志,2005,19(1):16-18. 被引量:68
  • 3陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2010:282.
  • 4高长昀,江毅,肖骏,胡有志.胺碘酮与利多卡因对急性心肌梗死并室性心律失常的疗效比较[J].华中科技大学学报(医学版),2007,36(4):542-543. 被引量:30
  • 5中华医学会心血管病学分会.中国生物医学工程学会心律分会,胺碘酮抗心律失常治疗应用指南工作组.胺碘酮抗心律失常治疗应用指南(2008)精编[J].中国社区医师,2009,6(25):11.
  • 6Brinker A, Johnston M.Acute pulmonary injury in association with amiodarone [J].Chest, 2004,125 (4) :1591.
  • 7Senoo K,Lane D,Lip GY. Stroke and bleeding risk in atrial fi- brillation[J]. Korean Circ J, 2014,44 (5) : 281-290.
  • 8A.J. Workman,G.L. Smith,A.C. Rankin.??Mechanisms of termination and prevention of atrial fibrillation by drug therapy(J)Pharmacology and Therapeutics . 2011 (2)
  • 9Burashnikov Alexander,Belardinelli Luiz,Antzelevitch Charles.Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria. Heart rhythm : the official journal of the Heart Rhythm Society . 2010
  • 10Incidence and predictors of asymptomatic atrial fibrillation in patients older than 70 years with complete atrioventricular block and dual chamber pacemaker implantation(J)Croatian Medical Journal . 2011 (1)

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部